These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 28633138)
41. Potentiation of cytokine-induced proliferation of human Natural Killer cells by intravenous immunoglobulin G. Issekutz AC; Derfalvi B; Käsermann F; Rowter D Clin Immunol; 2015 Dec; 161(2):373-83. PubMed ID: 26307433 [TBL] [Abstract][Full Text] [Related]
42. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood. Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068 [TBL] [Abstract][Full Text] [Related]
43. The regulation and biological activity of interleukin 12. Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557 [TBL] [Abstract][Full Text] [Related]
44. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928 [TBL] [Abstract][Full Text] [Related]
45. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells. Kozlowska AK; Tseng HC; Kaur K; Topchyan P; Inagaki A; Bui VT; Kasahara N; Cacalano N; Jewett A Cancer Immunol Immunother; 2016 Sep; 65(9):1085-97. PubMed ID: 27439500 [TBL] [Abstract][Full Text] [Related]
46. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. Leite-De-Moraes MC; Hameg A; Arnould A; Machavoine F; Koezuka Y; Schneider E; Herbelin A; Dy M J Immunol; 1999 Dec; 163(11):5871-6. PubMed ID: 10570271 [TBL] [Abstract][Full Text] [Related]
47. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Leong JW; Chase JM; Romee R; Schneider SE; Sullivan RP; Cooper MA; Fehniger TA Biol Blood Marrow Transplant; 2014 Apr; 20(4):463-73. PubMed ID: 24434782 [TBL] [Abstract][Full Text] [Related]
48. Interleukin-12 induces interferon-gamma expression and natural killer cytotoxicity in cord blood mononuclear cells. Lau AS; Sigaroudinia M; Yeung MC; Kohl S Pediatr Res; 1996 Jan; 39(1):150-5. PubMed ID: 8825401 [TBL] [Abstract][Full Text] [Related]
49. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. Arase H; Arase N; Saito T J Exp Med; 1996 May; 183(5):2391-6. PubMed ID: 8642351 [TBL] [Abstract][Full Text] [Related]
50. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma. Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395 [TBL] [Abstract][Full Text] [Related]
51. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4. Salvucci O; Mami-Chouaib F; Moreau JL; Thèze J; Chehimi J; Chouaib S Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963 [TBL] [Abstract][Full Text] [Related]
52. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. Orange JS; Biron CA J Immunol; 1996 Jun; 156(12):4746-56. PubMed ID: 8648121 [TBL] [Abstract][Full Text] [Related]
53. IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells. Kozar K; Kaminski R; Giermasz A; Basak G; Zagozdzon R; Rybczynska J; Wasik M; Lasek W; Jakobisiak M; Golab J Oncol Rep; 2002; 9(2):427-31. PubMed ID: 11836621 [TBL] [Abstract][Full Text] [Related]
54. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899 [TBL] [Abstract][Full Text] [Related]
55. HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines. Vitale M; Caruso A; De Francesco MA; Rodella L; Bozzo L; Garrafa E; Grassi M; Gobbi G; Cacchioli A; Fiorentini S Br J Haematol; 2003 Jan; 120(2):337-43. PubMed ID: 12542496 [TBL] [Abstract][Full Text] [Related]
56. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Wang KS; Frank DA; Ritz J Blood; 2000 May; 95(10):3183-90. PubMed ID: 10807786 [TBL] [Abstract][Full Text] [Related]
57. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. Strengell M; Matikainen S; Sirén J; Lehtonen A; Foster D; Julkunen I; Sareneva T J Immunol; 2003 Jun; 170(11):5464-9. PubMed ID: 12759422 [TBL] [Abstract][Full Text] [Related]
58. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells. Ewen EM; Pahl JHW; Miller M; Watzl C; Cerwenka A Eur J Immunol; 2018 Feb; 48(2):355-365. PubMed ID: 29105756 [TBL] [Abstract][Full Text] [Related]
59. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer. Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450 [TBL] [Abstract][Full Text] [Related]
60. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells. Sabel MS; Arora A; Su G; Mathiowitz E; Reineke JJ; Chang AE Surgery; 2007 Nov; 142(5):749-60. PubMed ID: 17981196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]